| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
6.4 0.07 (0.01%) |
01-15 16:00 |
|
Open: |
6.36 |
Pre close: |
6.33 |
Target:
|
7.97
|
|
High: |
6.65 |
Low: |
6.21 |
Resistance:
|
6.82
7.97
|
|
Volume: |
142,097 |
Market Cap: |
30M |
Support:
|
5.30
4.36
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.21
 |
MACD |
MACD(12,26):
|
0.34 |
|
MA(20): |
5.48 |
Signal(12,26,9): |
0.25 |
|
MA(100): |
5.04 |
Stochastic Oscillator |
%K(14,3):
|
77.10 |
|
MA(250): |
6.71  |
%D(3): |
74.07 |
|
Average Volume(K) |
3-Month: |
21764
|
52-Week |
High:
|
13.80 |
|
10-Days: |
29163 |
Low: |
3.78 |
|
RSI |
RSI(14):
|
63.89 |
Change(%): |
-31.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.720 |
Return on Equity (ttm) |
-94.6 |
Shares Out. (M) |
4.74 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-28.4 |
Shares Float (M) |
1.56 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.05 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
-67.1 |
% Held by Institutions |
33.14 |
|
Forward EPS |
-0.510 |
Gross Profit (p.s.) |
-0.059 |
Shares Short (K) |
234 |
|
Book Value (p.s.) |
2.280 |
EBITDA (p.s.) |
-3.903 |
P/E |
-1.36 |
|
Sales Per Share |
2.272 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.81 |
|
Profit Margin |
-194.78 |
Operating Cash Flow
(M) |
-16.60 |
P/S |
2.82 |
|
Operating Margin |
-184.63 |
Levered Free Cash Flow
(M) |
-11.09 |
P/CF |
-1.83 |
|
|
|
|
|
|
